Homocysteine, hypertension, and risks of cardiovascular events and all-cause death in the Chinese elderly population: a prospective study. - Concepedia

Concepedia

Publication | Open Access

Homocysteine, hypertension, and risks of cardiovascular events and all-cause death in the Chinese elderly population: a prospective study.

DOI Full Paper Access

16

Citations

34

References

2021

Year

Zhongying Zhang, Xiang Gu, Zhe Tang, Shaochen Guan, Hongjun Liu, Xiaoguang Wu, Yan Zhao, Xianghua Fang

Abstract

Hyperhomocysteinemia was an independent risk factor, and when accompanied by hypertension, it contributed to incident CVD events and all-cause death in the Chinese elderly population without a history of CVD.

References

	Year	Citations
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Paul A. James, Suzanne Oparil, Barry L. Carter, JAMA HypertensionHeart FailureHigh Blood PressureBlood PressureNon-pharmacological Intervention	2013	7.9K
Guidelines for the Primary Prevention of Stroke Cheryl Bushnell, Seemant Chaturvedi, Mark A. Creager, Stroke Cerebrovascular DiseaseThrombosisStroke RehabilitationStrokeNeurology	2014	2.6K
Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death James F. Toole, M.R. Malinow, Lloyd E. Chambless, JAMA	2004	1.4K
2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. PubMed HypertensionPreventive MedicineCardiovascular DiseaseHealth PolicyAntihypertensive Therapy	2019	777
Efficacy of Folic Acid Therapy in Primary Prevention of Stroke Among Adults With Hypertension in China Yong Huo, Jianping Li, Xianhui Qin, JAMA	2015	716
Homocyst(e)ine, Diet, and Cardiovascular Diseases M.R. Malinow, Andrew G. Bostom, Ronald M. Krauss Circulation ObesityNutritionMetabolic SyndromeMetabolic DisorderPhysiology	1999	589
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. Christine M. Albert, Nancy R. Cook, J. Michael Gaziano, PubMed	2008	505
Effect of Homocysteine Lowering on Mortality and Vascular Disease in Advanced Chronic Kidney Disease and End-stage Renal Disease Rex L. Jamison, Pamela Hartigan, James S. Kaufman, JAMA	2007	449
Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography Marta Ebbing, Øyvind Bleie, Per Magne Ueland, JAMA	2008	412
Epidemiological Transition of Stroke in China Dong Zhao, Jing Liu, Wei Wang, Stroke	2008	347

Page 1